Navigation Links
Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance
Date:7/28/2009

of $1.7 million from acquisitions, additional stock and severance compensation of $1.3 million and other increases of $1.2 million.

Other operating costs increased $2.3 million, or 5.9%, in the second quarter of 2009 over the same quarter in the prior year due to additional variable compensation accruals of $2.0 million, higher occupancy costs of $0.3 million, other operating costs of acquisitions of $0.4 million and additional bad debt expense of $0.9 million, offset by lower professional fees of $0.9 million and $0.4 million of reductions in other overhead costs. As a percentage of sales other operating costs decreased by 20 basis points compared to the second quarter of last year.

Interest expense for the second quarter of 2009 was $0.5 million less than the same period of last year due to lower variable interest rates.

Net sales for the six months ended June 30, 2009 increased by $23.9 million, or 7.0%, to $362.7 million from $338.8 million in the same period last year. The sales growth was principally the result of a $13.1 million, or 4.4%, increase in same-center sales in our patient care centers, a $2.9 million, or 7.1%, increase in sales of the Company's distribution segment and a $7.9 million increase related to sales from acquired entities.

Cost of materials increased $7.9 million, or 7.7%, to $109.9 million in the six months ended June 30, 2009 compared to the same quarter last year principally due to the sales increase. Cost of materials as a percentage of sales increased by 20 basis points to 30.3% for the first half of 2009 compared to 30.1% for the first half of 2008.

Personnel costs increased by $7.9 million, or 6.5%, for the first half of 2009 compared to the same period in 2008. Contributing to this increase were personnel costs of $3.2 million related to acquisitions, additional stock and severance compensation of $1.8 million and other incre
'/>"/>

SOURCE Hanger Orthopedic Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Hanger Orthopedic Group, Inc. Announces Second Quarter 2009 Earnings Release Conference Call
2. Hanger Orthopedic Group, Inc. Receives Upgrade from Standard & Poors Rating Services
3. Hanger Orthopedic Group, Inc. Announces Two Acquisitions Totaling $5.3 Million of Annual Net Revenue
4. Hanger Orthopedic Group, Inc. Reports $0.14 EPS on 26.6% Increase in Net Income for the First Quarter 2009
5. Hanger Orthopedic Group, Inc. Announces First Quarter 2009 Earnings Release Conference Call
6. Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008
7. Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth Officer
8. Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue
9. Hanger Orthopedic Group, Inc. Announces 2008 Year-End Earnings Release Conference Call
10. Parker College of Chiropractic Education Launches Recruiting Campaign for Career Changers and Potential Students
11. Hanger Orthopedic Group, Inc. Receives Favorable New Code for WalkAide

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... simple question has been the focus of intense res...ulates High Blood Pressure in Mice & Men, Does st...n has been the focus of intense research for many ...tablished a link between a novel gene, phosducin, ...as well as humans. The studies were directed by sc...
(Date:11/25/2009)...atment clinics to resume Monday, Nov. 30 , ...009 -- Centegra Health System is continuing to off...our Centegra Primary Care (CPC) vaccination clinic...he clinics are at CPC sites in Huntley, Woodstock,...ows: ,   From 4:30 to 7:30 p.m. Tuesda...
(Date:11/25/2009)... trouble with the H1N1 vaccine, , , WED...N1 swine flu pandemic may be driving a recent spik...a U.S. health official said Wednesday. , "We ar...tions around the country," Dr. Anne Schuchat, dire...espiratory Diseases at the U.S. Centers for Diseas...
(Date:11/25/2009)...aightYear ,, WASHINGTON,Nov.25/PRNewswire-USN...A)issuedthe 4thAnnualReportCardonLungCancer .ThisR...ethaldiseaseinthestateofGeorgia.LCA-GAisachapterof...ndedicatedexclusivelytopatientsupportandadvocacyfo...o: http://www.newscom.com/cgi-bin/prnh/20081016/LC...
(Date:11/25/2009)...ur in children with autism and related conditions ... medication combined with a structured training pr...searchers and their colleagues. , Published in ...rican Academy of Child and Adolescent Psychiatry ,... of Mental Health (NIMH) Research Units on Pediatr...
Breaking Medicine News(10 mins):Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2
...elhi Chief Minister Sheila Dikshit Monday launched...ll in the capital.// The mission "would not ... would also lay equal importance to aspects of pre...d reliable primary healthcare service and effectiv...
...ews of interest for post menopausal women with bre...-addition of both Herceptin (trastuzumab) from Roc...o their treatment improves the length of progressi... after which the cancer continued to progress. ...
...tem cells to reverse the signs of aging are now th...re skeptical about the significance of the stem ce...ne lines. "The whole stem cell thing is by f... much." He said that researchers are "in the...
...remature births appear to be a bigger threat to ba...ccording to a new study from the U.S. Centers// fo...infant deaths in 2002 were linked to prematurity, ...h of Dimes' Perinatal Data Center, said, "We have ...
...oughing vigorously until an ambulance arrives coul..., said researchers.// Tadeusz Petelenz and c...ce, Poland, studied 115 people who had previously ...ecognise the symptoms - sudden dizziness and weakn...
...o understand the influence of economic, social and...State researchers have designed an index labeled ‘...ssociate professor of criminal justice, and Dr. St...f the Journal of Black Studies. "There are m...
Other Medicine News:Health News:Stem Cells –To Lift Wrinkle 2Health News:One third of Infant Deaths from Premature Births in U.S. 2Health News:Understanding Stress Triggers for African Americans 2
(Date:11/24/2009)...d.,Nov.24/PRNewswire-Asia/--ChindexInternational,I...AmericanproviderofWestern,healthcareproductsandser...hattheCompanywillattendthe21stAnnualPiperJaffray,"...,2009,atthe,NewYorkPalaceHotel. , Managementi...December1,2009,andholdone-on-onemeetingsthroughout...
(Date:11/24/2009)...J.,Nov.24/PRNewswire-FirstCall/--QuestDiagnosticsI...fdiagnostictesting,informationandservices,announce...ayHealthcareConferenceinNewYorkCity.Thepresentatio...asternTime. ,, Duringtheconference,thecompanywi...mate3%,operatingincometoexceed18%ofrevenues,anddil...
(Date:11/24/2009)...AKE,N.J.andNEWYORK,Nov.24/PRNewswire/-- EisaiInc....ministration(FDA)hasacceptedforreviewEisai,sNewDru...epezilHClextendedrelease)tabletsforthetreatmentofm...rdoseformulationcontains23mgofdonepezilHClinanexte...atallowsforgradualreleaseofthedrug.TheNDAisbasedon...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Soyfoods a Healthy Choice for Men 48575 1Soyfoods a Healthy Choice for Men 48575 2Soyfoods a Healthy Choice for Men 48575 3Soyfoods a Healthy Choice for Men 48575 4Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 1Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 2Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 3Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 4Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 1Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 2Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 3Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 4
...il 16 Simbionix, the world,s leading,developer of...reement with,Johnson & Johnson LLC for distrib...ts. , Johnson & Johnson, LLC operates in R... subsidiaries of Johnson & Johnson. , John...o distribute,Simbionix,s line of advanced medical ...
...The following letter is being released by CEL-SCI ...s: , , Dear Fellow Shareholders: , , A very imp... Dendreon Corporation has announced that its pivot...et its primary endpoint of improving overall survi...from the 512 patient study will be presented on Ap...
Other Medicine Technology:Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries 2CEL-SCI Corporation Releases Letter to Shareholders 2CEL-SCI Corporation Releases Letter to Shareholders 3
Ocular Four Mirror Mini Gonio
Ocular Single Mirror Gonio
Mcintyre Straight Lachrymal Cannula
McIntyre Lacrimal Cannula
Medicine Products: